Mortensen, A. C. L., Mohajershojai, T., Gustafsson, A., Berglund, H., Selvaraju, R. K., Hofström, C., . . . Lund University, F. o. E. (2025). Preclinical Validation of [177Lu]Lu-AKIR001, a CD44v6-Targeted Radiotherapeutic Entering First-in-Human Trials. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. https://doi.org/10.2967/jnumed.125.270782
Chicago-Zitierstil (17. Ausg.)Mortensen, Anja C L., et al. "Preclinical Validation of [177Lu]Lu-AKIR001, a CD44v6-Targeted Radiotherapeutic Entering First-in-Human Trials." Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine 2025. https://doi.org/10.2967/jnumed.125.270782.
MLA-Zitierstil (9. Ausg.)Mortensen, Anja C L., et al. "Preclinical Validation of [177Lu]Lu-AKIR001, a CD44v6-Targeted Radiotherapeutic Entering First-in-Human Trials." Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, 2025, https://doi.org/10.2967/jnumed.125.270782.